Part Two of the Intentional Adulteration Webinar series will review the FDA draft guidance on the rule. This has been rescheduled for Tuesday, July 24, 2018 at 11am (ET). ASTA delayed this webinar originally scheduled to be presented in June until FDA published the draft guidance. Part One is now available as a recording and registration for Part Two is open. To learn more about this series, click here. For questions, contact ASTA at [email protected] or (202) 331-2460.